Stemtech (STEK) Gross Margin (2021 - 2025)

Stemtech has disclosed Gross Margin across 5 years of filings, most recently posting 77.42% for Q4 2025.

• Gross Margin for Q4 2025 came in at 77.42%, down 213.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 80.29% (up 653.0% YoY), and the FY2025 annual result was 80.29%, up 653.0% from the prior year.
• Gross Margin came in at 77.42% for Q4 2025 at Stemtech, down from 80.08% in the prior quarter.
• In the past five years, Gross Margin ranged from a high of 86.07% in Q3 2021 to a low of 63.15% in Q3 2024.
• The 5-year median for Gross Margin is 77.89% (2023), against an average of 76.91%.
• Across the five-year window, Gross Margin tumbled 1445 bps in 2024 and surged 1693 bps in 2025, its largest moves.
• Stemtech's Gross Margin stood at 65.91% in 2021, then grew by 6 bps to 69.66% in 2022, then increased by 20 bps to 83.86% in 2023, then fell by 5 bps to 79.55% in 2024, then retreated by 3 bps to 77.42% in 2025.
• The last three Gross Margin figures came in at 77.42% (Q4 2025), 80.08% (Q3 2025), and 79.09% (Q2 2025), per Business Quant data.